Jonathan Halperin
Program Director · Icahn School of Medicine at Mount Sinai
Credentials: · · · ·
History
- Present
Mount Sinai Fuster Heart Hospital
- 1981–1982
- 1978–1981
1971–1975
Research
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
New England Journal of Medicine · 2011 · 7,354 citations
Edoxaban versus warfarin in patients with atrial fibrillation
New England Journal of Medicine · 2013 · 4,099 citations
Circulation · 2014 · 3,326 citations
80 papers
65 papers
61 papers
58 papers · 3 as a fellow
52 papers
52 papers
51 papers
- CN
48 papers
Grants
- 1994–1999
Transesophageal Echocardiography in Atrial Fibrillation
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1M · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2009–2011
Genetic Response to Warfarin in Healthy Subjects
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
- 2008–2013
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
Study chair · Terminated · Phase 4
Biotronik, Inc.